Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) EBT (2021 - 2025)

Biote has reported EBT over the past 5 years, most recently at $5.6 million for Q4 2025.

  • Quarterly results put EBT at $5.6 million for Q4 2025, up 559.26% from a year ago — trailing twelve months through Dec 2025 was $37.6 million (up 3599.21% YoY), and the annual figure for FY2025 was $37.6 million, up 3599.21%.
  • EBT for Q4 2025 was $5.6 million at Biote, down from $8.5 million in the prior quarter.
  • Over the last five years, EBT for BTMD hit a ceiling of $23.5 million in Q3 2023 and a floor of -$21.7 million in Q2 2022.
  • Median EBT over the past 5 years was $5.8 million (2025), compared with a mean of $3.2 million.
  • Biggest five-year swings in EBT: soared 8826.77% in 2022 and later tumbled 320.95% in 2023.
  • Biote's EBT stood at $5.6 million in 2021, then soared by 138.35% to $13.2 million in 2022, then tumbled by 31.79% to $9.0 million in 2023, then plummeted by 113.5% to -$1.2 million in 2024, then soared by 559.26% to $5.6 million in 2025.
  • The last three reported values for EBT were $5.6 million (Q4 2025), $8.5 million (Q3 2025), and $6.1 million (Q2 2025) per Business Quant data.